LORBRENA vs SORAFENIB TOSYLATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. LORBRENA and SORAFENIB TOSYLATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LORBRENA	SORAFENIB TOSYLATE
Rating	64/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	LORLATINIB	SORAFENIB TOSYLATE
Manufacturer	Pfizer	Yabao Pharm
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	—	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

lorbrena sorafenib tosylate

Rating

64/100

New

Pharmacy pays

—

Type

Active ingredient

LORLATINIB

SORAFENIB TOSYLATE

Manufacturer

Pfizer

Yabao Pharm

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

—

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Frequently asked questions

What is the difference between Lorbrena and Sorafenib Tosylate?

Lorbrena contains Lorlatinib, while Sorafenib Tosylate contains Sorafenib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.